The proteoglycan mimecan is associated with carotid plaque vulnerability and increased risk of future cardiovascular death.
Tengryd C, Nielsen SH, Cavalera M, Bengtsson E, Genovese F, Karsdal M, Dunér P, Orho-Melander M, Nilsson J, Edsfeldt A, et al. Atherosclerosis. 2020 Nov; 313:88-95. Epub 2020 Sep 25.